Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
1.
Braz. J. Pharm. Sci. (Online) ; 58: e19702, 2022. tab
Artículo en Inglés | LILACS | ID: biblio-1394037

RESUMEN

Abstract Substance use disorder is one of the major social and public health problems in the world. The present study analyzed the pharmacoepidemiological profile of patients treated at the Psychosocial Treatment Center for Alcohol and Substance Use Disorders (CAPS-AD) for treatment of alcohol use disorders (AUD), cocaine use disorders (CUD) and concomitant alcohol and cocaine use disorders (A-CUD) in the city of Betim-MG. The study used quantitative and descriptive data and was based on the evaluation of medical records of patients attended from January to December 2016. After analyzing 295 medical records, the majority of study participants were male (83.7 %) with an average age of 46.26 for AUD, 28.88 for CUD and 34.29 for A-CUD. The most prescribed drugs for AUD were diazepam (54.1 %), thiamine (37 %), complex B vitamins (29.5 %), and disulfiram (2.7 %); for CUD, diazepam (26.9 %) and haloperidol (23.1 %). It should be noticed that although contraindicated by the guidelines, chlorpromazine (42.3 %, 25.3 %, 20.3 %) was prescribed for CUD, AUD, and A-CUD respectively. Knowing the pharmacoepidemiological profile of CAPS-AD patients is extremely important for making decisions regarding which medicines to make available to the population.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Trastornos Relacionados con Alcohol/tratamiento farmacológico , Trastornos Relacionados con Cocaína/tratamiento farmacológico , Quimioterapia/instrumentación , Pacientes/clasificación , Clorpromazina/efectos adversos , Salud Pública/instrumentación , Diazepam/efectos adversos , Disulfiram/efectos adversos , Disulfiram/agonistas
2.
Int. j. odontostomatol. (Print) ; 14(1): 19-26, mar. 2020. graf
Artículo en Inglés | LILACS | ID: biblio-1056496

RESUMEN

ABSTRACT: Anxiety in dental surgery may lead to behavioral and physiological changes for the patient and constitute a frequent challenge for the oral surgeon. The objective of this study was to compare the effect of inhalatory nitrous oxide and oxygen (N2O/O2) with oral diazepam conscious sedation in vital signs of patients undergone third molar extraction. Outpatients who needed removal of partially impacted, bilateral lower third molars, during the period of one year, were included. Each patient underwent conscious sedation with either oral diazepam or inhalatory N2O/O2 on a randomized controlled trial, split-mouth design. Systolic and diastolic blood pressure, heart rate and oxygen blood saturation were the changes measured before, at the beginning and the end of the procedure. Also, surgical procedure duration was recorded. Data from vital signs were submitted to analysis of variance and the duration of the surgery to paired Student's t-test. Twenty-five healthy outpatients (13 women and 12 men) with a mean age of 21.6 years were studied. There was an increase in systolic and diastolic pressure and in heart rate in the beginning; these values decreased and stabilized at the end of the surgical procedure in both treatments (p < 0.001) being lower in N2O/O2 but without difference between treatments. The surgical procedure duration was lower and occurred an expected increase of oximetry under N2O/O2 sedation (p < 0.001). Both treatments were effective for the conscious sedation but N2O/O2 showed better outcomes, mainly in duration of the surgery.


RESUMEN: La ansiedad en la cirugía dentoalveolar puede conducir a alteraciones fisiológicas y de comportamiento en el paciente, constituyendo así un desafío frecuente para el cirujano maxilofacial. El objetivo de este estudio fue comparar el efecto del óxido nitroso inhalatorio con oxígeno (N2O/O2) y la sedación consciente oral con diazepam por médio de los signos vitales de pacientes sometidos a la extracción del tercer molar. Fueron incluídos pacientes ambulatoriales com necesidad de exodoncia de terceros molares inferiores bilaterales, parcialmente impactados, durante el período de un año. Cada paciente fue sometido a sedación consciente con diazepam oral o N2O/O2 por inhalación en un ensayo controlado aleatorio, diseño de boca dividida. La presión arterial sistólica y diastólica, la frecuencia cardíaca y la saturación de oxígeno en la sangre fueron medidos antes, al inicio y al final del procedimiento. Además, se registró la duración del procedimiento quirúrgico. Los datos de los signos vitales fueron enviados para análisis de varianza y la duración de la cirugía para la prueba t de Student pareada. Se estudiaron 25 pacientes ambulatorios sanos (13 mujeres y 12 hombres) con una edad media de 21,6 años. Al início hubo un aumento en la presión sistólica y diastólica y en la frecuencia cardíaca; estos valores disminuyeron y se estabilizaron al final del procedimiento quirúrgico en ambos tratamientos (p <0,001), siendo más bajos en N2O/ O2 pero sin diferencia entre los tratamientos. La duración del procedimiento quirúrgico fue menor y se produjo un aumento esperado de la oximetría bajo sedación con N2O/O2 (p <0,001). Ambos tratamientos fueron efectivos para la sedación consciente, pero el N2O/O2 mostró mejores resultados, principalmente en la duración de la cirugía.


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Diente Impactado/cirugía , Sedación Consciente/métodos , Diazepam/efectos adversos , Tercer Molar/cirugía , Óxido Nitroso/efectos adversos , Presión Sanguínea , Brasil , Oximetría/métodos , Administración Oral , Frecuencia Cardíaca , Óxido Nitroso/administración & dosificación
3.
Braz. J. Pharm. Sci. (Online) ; 56: e18819, 2020. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1249169

RESUMEN

The plant world represents an important source of potential therapeutic agents, but concomitant administration of herbal and conventional medications may result in interactions with subsequent beneficial or adverse effects. This study was designed to examine the analgesic effect of thyme tincture and thyme syrup, two commonly used thyme formulations, and their interactions with codeine, paracetamol, pentobarbital and diazepam in mice. The identification and quantification of thymol and carvacrol were carried out by GC/MS and GC/FID. The analgesic activity was studied using a hot plate method. Effects of thyme syrup on diazepam-induced motor coordination impairment in rotarod test and on pentobarbital-induced sleeping time were also determined. Thymol (175.3 µg/mL and 9.73 µg/mL) and carvacrol (10.54 µg/mL and 0.55 µg/mL) concentrations were measured in tincture and syrup, respectively. Thyme syrup and tincture exhibited effective analgesic activity in the hot plate pain model. Pretreatment with thyme formulations reduced analgesic activity of codeine, and potentiated the analgesic activity of paracetamol. Co-administration of thyme formulations has led to potentiation of diazepam and pentobarbital depressive central nervous system effects. Thyme formulations interacted with tested conventional drugs, probably through interference with their metabolic pathways and succeeding altered concentrations and pharmacological effects.


Asunto(s)
Animales , Masculino , Femenino , Ratones , Thymus (Planta)/efectos de los fármacos , Interacciones Farmacológicas , Analgésicos/efectos adversos , Pentobarbital/efectos adversos , Preparaciones Farmacéuticas , Diazepam/efectos adversos , Medicamento Fitoterápico
4.
Rev. Soc. Bras. Clín. Méd ; 17(4): 180-182, dez 2019.
Artículo en Portugués | LILACS | ID: biblio-1284242

RESUMEN

Objetivo: Avaliar a prevalência da polifarmácia e da prescrição de medicações inapropriadas, bem como suas associações com a capacidade cognitiva e funcional do idoso. Métodos: Estudo observacional transversal, no qual foram analisadas as medicações prescritas em 141 prontuários para pacientes acima de 50 anos, em associação com testes que quantificaram a capacidade funcional e cognitiva deles. Resultados: Observou-se média de 4,41 medicamentos por paciente, sendo que 0,41 deles foram considerados inapropriado, segundo o critério de Beers. Verificou-se também relação estatisticamente significativa quanto ao número de medicações e testes que mediam a capacidade funcional e cognitiva dos idosos. Conclusão: O aumento da polifarmácia e da prescrição de medicações potencialmente inadequadas acarretou significativa piora da capacidade cognitiva e funcional do idoso


Objective: To evaluate the prevalence of polypharmacy and of the prescription of inappropriate medications, as well as their associations with the cognitive and functional capacity of the elderly. Methods: Cross-sectional observational study which analyzed the drugs prescribed in 141 medical records for patients over 50 years of age, associated with tests that quantified their functional and cognitive capacity. Results: An average of 4.41 medications per patient was observed, and 0.41 were considered inappropriate according to the Beers criteria. There was also a statistically significant relation regarding the number of medications and tests that measure the functional and cognitive capacity of the elderly. Conclusion: The increase in polypharmacy and in the prescription of potentially inappropriate medications led to a significant impairment of the cognitive and functional capacity of the elderly


Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Perfil de Salud , Anciano , Cognición/efectos de los fármacos , Polifarmacia , Persona de Mediana Edad , Omeprazol/uso terapéutico , Brasil/epidemiología , Enalapril/uso terapéutico , Comorbilidad , Aspirina/uso terapéutico , Registros Médicos/estadística & datos numéricos , Prevalencia , Estudios Transversales , Clonazepam/efectos adversos , Distribución por Edad , Losartán/uso terapéutico , Simvastatina/uso terapéutico , Diabetes Mellitus/epidemiología , Diazepam/efectos adversos , Dislipidemias/epidemiología , Tiazidas/uso terapéutico , Prescripción Inadecuada/estadística & datos numéricos , Zolpidem/efectos adversos , Amitriptilina/efectos adversos , Hipertensión/epidemiología , Hipoglucemiantes/uso terapéutico
5.
JABHS-Journal of the Arab Board of Health Specializations. 2010; 11 (3): 62-66
en Arabe | IMEMR | ID: emr-144938

RESUMEN

A study on intravenous sedation in dental surgery was conducted comparing diazepam with midazolam. One hundred and twenty patients, aged between 12 and 50 years, ASA grade I or II divided randomly into two groups. A total of 80 patients received diazepam 0.03 mg/kg with fentanyl 0.7 microg/kg [Group-A], and 40 patients received midazolam 0.03 mg/kg with fentanyl 0.7 microg/kg [group-B]. In both groups, the dental surgeon gave 1.5-3 ml xylocaine 0.5% with adrenaline 1:200.000 to perform the nerve block to the upper or lower jaw as needed. No premedication was given. Perioperative cardiovascular effects, anterograde amnesia, respiration, oxygen saturation, patient satisfaction and adverse venous sequelae were investigated. Blood pressure was reduced in both groups; the reduction was less than 30 mmHg, the difference was not significant. In diazepam group [A], 30% were able to remember the events, 25% suffered painful injection, 10% suffered redness and swelling at site of injection. In midazolam group [B], 10% were able to remember the events, no patient suffered redness and swelling at site of injection or painful injection, the difference was statistically significant for these adverse effects. Both drugs gave safe and acceptable sedation. Midazolam was superior to diazepam, had better amnesic effects, more patient satisfaction with no incidence of venous sequelae


Asunto(s)
Humanos , Adolescente , Adulto , Persona de Mediana Edad , Masculino , Femenino , Sedación Consciente , Midazolam , Anestésicos Intravenosos , Diazepam , Diazepam/efectos adversos
6.
Rev. ciênc. farm. básica apl ; 27(3): 259-267, 2006. tab
Artículo en Portugués | LILACS | ID: lil-466209

RESUMEN

Propôs-se caracterizar o perfil de utilização do diazepam na população idosa (60 anos ou mais) usuária crônica, atendida no serviço de atenção primária de Tatuí-SP e estabelecer uma relação entre uso crônico, efeitos adversos, dependência e as recomendações preconizadas na literatura científica. Desenvolveu-se um estudo observacional, transversal, através de entrevistas semiestruturadas aplicadas em 70 idosos. Trata-se de uma amostra não probabilística, por tipicidade, de caráter voluntário. A amostra selecionada era composta por: 77,1% mulheres e 22,9% homens, sendo, 37,1% casados, 44,2% viúvos, 92,8% de baixa escolaridade, 94,2% aposentados e 91,4% portadores de doenças crônicas. O diagnóstico referido, que justificou a prescrição inicial em dose de 10mg/dia foi a ansiedade e a insônia (92,8%). Em 90% dos pacientes a orientação médica foi seguida, sem interrupção, por um tempo mediano de 60 meses com um mínimo de seis e máximo de 360 meses. Os possíveis efeitos adversos foram: tontura, dores articulares, angústia e depressão. Aqueles que tentaram não utilizar o medicamento (97,14%) relataram insônia, ansiedade e irritabilidade. Os dados deste estudo, sugerem que a dose padronizada pela rede pública de 10mg e o tempo de utilização não propicia uma prática consistente de elevação do bem estar desses usuários, visto que a maioria relatou efeitos adversos e síndrome de abstinência na ausência do medicamento; tornando-se conveniente uma cuidadosa monitorização clínica e uma orientação quanto à redução gradativa da dose.


Asunto(s)
Humanos , Masculino , Femenino , Anciano , Anciano de 80 o más Años , Anciano , Atención Primaria de Salud/estadística & datos numéricos , Diazepam/administración & dosificación , Diazepam/efectos adversos , Centros de Salud
7.
Medical Journal of Cairo University [The]. 2005; 73 (4): 715-717
en Inglés | IMEMR | ID: emr-73395

RESUMEN

The objective of this study was to evaluate the efficacy of intermittent oral diazepam for reducing the recurrence of febrile seizures.Prince Rushed military hospital north of Jordan. Prospective controlled study of 280 patients, who were admitted to pediatric ward with first febrile seizures and were r and omized into two groups, one group received short-term prophylaxis for 12 months with oral diazepam 2.5Mg for children less than 7Kg, 5Mg for children weighing 7-15Kg and 10mg diazepam for children weighing more than 15kg and then continued after the temperature >38.5c, the control group received no prophylaxis Short-term diazepam prophylaxis reduces the recurrence rate of febrile seizures to one fifth that is from 43% to 8.2 [p<0.003] when the first febrile seizures are simple and to one-fourth that from 62% to 16% when the first febrile seizures are complex, with mild side effects of diazepam. Short-term prophylaxis with oral diazepam is effective in prevention of recurrence of febrile seizures, with mild side effects


Asunto(s)
Humanos , Masculino , Femenino , Diazepam , Recurrencia , Estudios Prospectivos , Diazepam/efectos adversos , Resultado del Tratamiento
9.
Arq. neuropsiquiatr ; 57(3B): 860-2, set. 1999. ilus
Artículo en Portugués | LILACS | ID: lil-247397

RESUMEN

Relatamos o caso de um paciente que após uso crônico de anticonvulsivantes, sem epilepsia definida, desenvolveu contraturas das aponeuroses palmar (doença de Dupuytren) e plantar (doença de Ledderhose). Discutimos as principais dessas complicações, os fatores predisponentes e sua estreita relação com o uso de anticonvulsivantes, particularmente de fenobarbital.


Asunto(s)
Humanos , Masculino , Adulto , Anticonvulsivantes/efectos adversos , Diazepam/efectos adversos , Contractura de Dupuytren/etiología , Enfermedades del Pie/etiología , Fenobarbital/efectos adversos , Fenitoína/efectos adversos , Anticonvulsivantes/uso terapéutico , Diazepam/uso terapéutico , Contractura de Dupuytren/cirugía , Epilepsia/tratamiento farmacológico , Enfermedades del Pie/cirugía , Fenobarbital/uso terapéutico , Fenitoína/uso terapéutico , Factores de Tiempo
10.
Neurosciences. 1999; 4 (4): 278-283
en Inglés | IMEMR | ID: emr-51921

RESUMEN

Frequent administration of diazepam has been reported to induce physical dependence and tolerance in animals and humans. Using an elevated plus-maze model of anxiety, we investigated whether vigabtrin reduces some of withdrawal symptoms of diazepam. Vigabatrin is irreversible inhibitor of the enzyme GABA-transaminase, which induces several increases in brain GABA levels. Previously, treatment of rats with vigabatrin for 14 days was found to produce an anxiolytiiclike effect without a changes in the general locomotor activity. In this study, rats were chronically treated with either diazepam at a dose of 10mg/kg/day, i.p. or vigabatrin at a dose of 200mg/kg/day, i.p. alone or in combination at a dose of 10mg/kg/day diazepam+200mg/kg/day for ivgabatrin for 14 days to examine their effects. The general locomotor activity of the rats did not alter in both groups of tolerance and dependence in comparison with control rats. An increases of horizontal activity of diazepam-dependent rats after 48 hrs of the last injections was observed without a changes in the vertical activity. In the dependence group, the anxiolytic effect of chronic treatment with diazepema was found to persist 48 hrs after last injection. However, the combined treatment of diazepam wth vigabatrin completely abolished the anxiolytic effect of diazepam [10mg/kg]. In the tolerance groups, the effect of 1.5mg/kg diazepam in chronically diazepam-treated rats was significantly lower than that of the control and chronically diazepam and vigabtrin-treated rats, with no difference between control group and combined treatment group. Forty-eight hours after the last injection, the concentration of GABA in the frontal cortex was significantly higher in the chronically treated was with vigabatrin than the other groups. A significantly decrease in the striatal GABA levels was found in acutely and chronically diazepam-treated rats. These findings may suggest that vigabatrin protects rats from development of some of withdrawal symptoms of benzodiazepines


Asunto(s)
Animales de Laboratorio , Diazepam/efectos adversos , Ratas , Síndrome de Abstinencia a Sustancias/veterinaria , Síndrome de Abstinencia a Sustancias/tratamiento farmacológico , Vigabatrin , Conducta Animal/efectos de los fármacos , Ácido gamma-Aminobutírico , Glicina
12.
Rev. bras. odontol ; 54(1): 34-8, jan.-fev. 1997. ilus, tab
Artículo en Portugués | LILACS, BBO | ID: lil-192962

RESUMEN

Este trabalho teve por objetivo avaliar os efeitos do diazepam e da dexametasona, associados à bupivacaína, sobre os valores de pressäo arterial sangüínea (PA) e freqüência cardíaca (FC), em pacientes submetidos a exodontia de terceiros molares mandibulares inclusos. As avaliaçöes da PA e da FC foram realizadas em cinco tempos distintos. Os resultados mostraram que os valores médios da pressäo arterial sangüínea (sistólica ediastólica) e da freqüência cardíaca situaram-se dentro da faixa de normalidade biológica, durante todo o período experimental


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Bupivacaína/efectos adversos , Dexametasona/efectos adversos , Diazepam/efectos adversos , Frecuencia Cardíaca , Presión Arterial , Tercer Molar , Extracción Dental
14.
Artículo en Inglés | IMSEAR | ID: sea-65051

RESUMEN

OBJECTIVE: To determine the effect of sedation using diazepam on hemoglobin oxygen saturation (SpO2) in patients undergoing esophagogastroduodenoscopy (EGD). METHOD: 100 consecutive patients scheduled for EGD were randomly allocated to receive 0.03 mL/Kg of either diazepam (5 mg/mL solution) or normal saline intravenously after topical oropharyngeal anesthesia immediately before the procedure. SpO2 was continuously monitored throughout the procedure by an anesthetist who was unaware of the drug received. RESULTS: Fall in SpO2 exceeding 4% was noted in 78% of patients in the diazepam group and in 38% of patients in the placebo group (p < 0.001). Fall in SpO2 to suboptimal level (89%) was seen in 20% of patients in the diazepam group and in 10% patients in the placebo group (p < 0.001). The duration of suboptimal SpO2 was similar (means +/- SD being 2.47 +/- 0.10 min in diazepam group and 2.86 +/- 0.32 min in placebo group). CONCLUSION: Intravenous diazepam administration before EGD produces a significant fall in SpO2 during the procedure, and so should be avoided; continuous monitoring of SpO2 should be done during EGD.


Asunto(s)
Adulto , Sedación Consciente/efectos adversos , Diazepam/efectos adversos , Endoscopía del Sistema Digestivo , Hemoglobinas/metabolismo , Humanos , Hipnóticos y Sedantes/efectos adversos , Persona de Mediana Edad , Oxígeno/sangre
15.
Rev. ADM ; 53(1): 41-5, ene.-feb. 1996. ilus
Artículo en Español | LILACS | ID: lil-175525

RESUMEN

Una dosis oral de 3 mg/kg diaria de diazepam (DZ) fue administrada a ratones Balb/C durante su gestación. Esta dosis causó una dependencia y sedación hasta de 4 horas. Las crías de estos ratones fueron sacrificadas en los días 1, 3, 7, 14, 21 y 28 postnatales y fueron examinados de anormalidades físicas. Los cráneos y las mandíbulas fueron disecados y pesados para analizarlas estadísticamente. Los ratones del grupo tratado con DZ mostraron un peso menor durante el período de gestación, en comparación con el grupo control. El peso de las mandíbulas y cráneos del grupo DZ también mostró un peso menor en los días 14, 21 y 28 postnatales. La aparición de un tumor en el cráneo fue un hallazgo clínico de esta investigación


Asunto(s)
Animales , Ratones , Anomalías Inducidas por Medicamentos/embriología , Cráneo/anatomía & histología , Cráneo/patología , Diazepam/efectos adversos , Mandíbula/anatomía & histología , Ratones Endogámicos BALB C
16.
Indian J Physiol Pharmacol ; 1995 Jul; 39(3): 293-5
Artículo en Inglés | IMSEAR | ID: sea-107778

RESUMEN

In a double blind short term clinical study, nitroxazepine has been found to be superior over placebo in reducing the diastolic blood pressure in mild hypertensive patients. In short term open clinical trial design nitroxazepine (25 mg PO, HS) has been found to be superior and better tolerated than diazepam (5 mg PO, HS). In open clinical trial design, nitroxazepine (25 mg PO, HS) reduced the diastolic blood pressure to the target level (100 mm Hg and less) effectively controlling the uncontrolled hypertensive patients receiving maintenance dose of beta blockers. There was no such beneficial effect in patients receiving maintenance doses of other antihypertensive drugs (pilot study). Adverse drug reactions like disturbed sleep in one, uneasiness in 3, palpitation in one and dryness of mouth in one patient have been observed.


Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Adulto , Antihipertensivos/efectos adversos , Presión Sanguínea/efectos de los fármacos , Diazepam/efectos adversos , Dibenzoxazepinas/efectos adversos , Método Doble Ciego , Humanos , Hipertensión/tratamiento farmacológico , Proyectos Piloto
17.
Indian J Exp Biol ; 1994 Dec; 32(12): 886-8
Artículo en Inglés | IMSEAR | ID: sea-61009

RESUMEN

Abrupt cessation of chronic treatment of diazepam (20 mg/kg/day for 21 days) produced withdrawal reactions. BR 16-A, a multicomponent herbal preparation shown to reverse the withdrawal reactions to opiates was studied against diazepam induced withdrawal reactions in mice. Acute dose of diazepam (20 mg/kg) produced a decrease in the ambulatory and total activity. However, chronic administration for 21 days produced tolerance and no significant change in the ambulatory and total activity. On abrupt termination of diazepam treatment after 21 days, the animals showed anxiety and excitement as there was an increase in ambulatory and total activity. The withdrawal excitement was highest at 72 hr of the last dose of diazepam. Concomittant administration of BR 16-A (100 and 500 mg/kg) reversed the acute effect of diazepam in a dose dependent manner. Similarly, chronic administration of BR 16-A (100 and 500 mg/kg/day for 21 days) with diazepam (20 mg/kg/day for 21 days) also reversed the withdrawal induced hyperambulation and total activity. Chronic administration of BR 16-A per se had no significant effect on the ambulatory and total activity, however, in acute doses, BR 16-A (100 and 500 mg/kg) produced a dose dependent increase in the ambulatory and total activity. BR 16-A with its CNS profile of activity could be a useful preparation in the management of substances of abuse.


Asunto(s)
Animales , Diazepam/efectos adversos , Femenino , Hipercinesia/inducido químicamente , Masculino , Medicina Ayurvédica , Ratones , Extractos Vegetales/uso terapéutico , Plantas Medicinales , Psicotrópicos/uso terapéutico , Síndrome de Abstinencia a Sustancias/tratamiento farmacológico
18.
Arq. bras. med ; 68(1): 15-20, jan.-fev. 1994. tab
Artículo en Portugués | LILACS | ID: lil-138194

RESUMEN

Consultas pagas foram feitas a pesquisadores (simulando ser pacientes) que procuraram 71 médicos em Säo Paulo e 36 em Recife, visando obter uma receita para emagrecer. Em 90,5 por cento das consultas de Säo Paulo e em 58,7 por cento das de Recife aos "pacientes" foram receitadas fórmulas magistrais, sendo ainda que em 9,5 por cento das de Säo Paulo e 37,9 por cento das de Recife foram prescritos produtos comerciais acabados. Nas fórmulas magistrais de 4 a 6 drogas (53,9 por cento das receitas de Säo Paulo e 27,5 por cento em Recife) mas houve prescriçöes contendo até 17 componentes. Os agentes anorexígenos mais prescritos foram o fenproporex (58,7 por cento em Säo Paulo e 47,2 por cento em Recife) e a anfepramona ou dietilpropiona (46,0 por cento em Sä Paulo e 37,4 por cento em Recife) mas mazindol, d,1-fenifluramina e d-fenfluramina foram também receitados. Sem exceçäo as fórmulas magistrais continham também benzodiazepínicos, sendo o diazepam (28,6 por cento em Sä Paulo e 27,5 por cento em Recife) e o clordiazepóxido (25,4 por cento em Säo Paulo e 21,9 por cento em Recife) os preferidos pelos médicos prescritores de fórmulas magistrais. Agentes diuréticos, tiroidianos, com açäo sobre o aparelho gastrointestinal plantas e substâncias várias completavam a receita. Notou-se também que em 19,0 por cento das receitas de Säo Paulo e em 6,9 por cento das de Recife havia prescriçäo de duas substâncias anorexígenas e que as doses prescritas chegavam até cinco vezes a posologia recomendada internacionalmente. A maior parte dos médicos näo advertiu os pesquisadores sobre as possíveis reaçöes adversas produzidas pelas substâncias anorexígenas e benxodiazepínicas, inclusive o perigo de dependência. Conclui-se que a prática de receitar fórmulas magistrais e medicamentos acabados à base de drogas anorexígenas e benzodiazepínicas é antes um risco do que benefício para a saúde


Asunto(s)
Humanos , Masculino , Femenino , Depresores del Apetito/efectos adversos , Benzodiazepinas/efectos adversos , Obesidad/tratamiento farmacológico , Práctica Profesional , Brasil , Diazepam/efectos adversos , Dietilpropión/efectos adversos , Fenfluramina/efectos adversos , Mazindol/efectos adversos
19.
Actual. pediátr ; 3(2): 62-8, jun. 1993. tab, graf
Artículo en Español | LILACS | ID: lil-190513

RESUMEN

El propósito de este estudio fue comparar la efectividad de estos tres tipos de tratamiento para prevenir las recurrencias de las convulsiones febriles durante el primer año posterior a la primera convulsión febril. Se trata de un trabajo prospectivo, tipo ensayo clínico controlado, abierto, no aleatorio. Se incluyeron finalmente 87 niños que consultaron al servicio de urgencias del Hospital Militar Central, por presentar una primera convulsión febril durante el período comprendido entre marzo de 1990 a junio de 1992. Los tres grupos de tratamiento se recomendaron así: fenobarbital como profilaxis continua 5 mg/Kg/día; diazepam 0,5 mg/Kg sublingual o rectal cada 12 horas en caso de presentar fiebre y acetaminofen 10 mg/Kg cada seis horas también en caso de fiebre. Presentaron recurrencias 2/29 pacientes tratados con diazepam, 9/28 niños tratados con fenobarbital y 12/30 casos que recibieron acetaminofen. Encontrándose una diferencia estadísticamente significativa (p<0.025) a favor del tratamiento con diazepam. En este trabajo no se encontró ninguna justificación para continuar recomendando la administración continua de fenobarbital en niños sanos con convulsiones febriles.


Asunto(s)
Humanos , Preescolar , Niño , Lactante , Convulsiones Febriles/clasificación , Convulsiones Febriles/diagnóstico , Convulsiones Febriles/tratamiento farmacológico , Convulsiones Febriles/etiología , Convulsiones Febriles/enfermería , Analgésicos no Narcóticos/administración & dosificación , Analgésicos no Narcóticos/efectos adversos , Analgésicos no Narcóticos/farmacocinética , Analgésicos no Narcóticos/farmacología , Analgésicos no Narcóticos/uso terapéutico , Diazepam/administración & dosificación , Diazepam/efectos adversos , Diazepam/farmacocinética , Diazepam/farmacología , Diazepam/uso terapéutico , Fenobarbital/administración & dosificación , Fenobarbital/efectos adversos , Fenobarbital/farmacocinética , Fenobarbital/farmacología
20.
Arq. neuropsiquiatr ; 50(2): 163-7, jun. 1992. tab
Artículo en Portugués | LILACS | ID: lil-120725

RESUMEN

Apresentamos a profilaxia intermitente com diazepam via oral como opçäo de tratamento para convulsäo febril. Justificamos essa proposta diante dos importantes efeitos colaterais que ocorrem com as duas medicaçöes classicamente usadas na profilaxia contínua (fenobarbital e valproato). Foram tratados 19 pacientes. Obtivemos resultados favoráveis, pois apenas um caso apresentou recorrência de convulsäo febril em vigência de dose adequada do diazepam. Houve efeitos colaterais transitórios em 36,8% da nossa casuística


Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Convulsiones Febriles/tratamiento farmacológico , Diazepam/uso terapéutico , Administración Oral , Diazepam/efectos adversos , Estudios Prospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA